Hayden Royal’s Pfizer PFE Stock Holding History

Hayden Royal’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$194K	Buy	+3,281	New	+$163K	0.45%	79
2021 Q3	–	Sell	-65,131	Closed	-$2.55M	–	163
2021 Q2	$2.55M	Sell	65,131 -2,633	-4%	-$102K	1.4%	17
2021 Q1	$2.46M	Buy	+67,764	New	+$2.41M	1.41%	17
2020 Q4	–	Sell	-74,210	Closed	-$2.58M	–	526
2020 Q3	$2.58M	Buy	74,210 +1,493	+2%	+$52.3K	1.38%	16
2020 Q2	$2.26M	Sell	72,717 -2,024	-3%	-$68.8K	1.27%	12
2020 Q1	$2.31M	Sell	74,741 -40,535	-35%	-$1.38M	1.36%	15
2019 Q4	$4.01M	Buy	115,276 +86,286	+298%	+$3.07M	2.03%	6
2019 Q3	$989K	Buy	28,990 +1,553	+6%	+$56.5K	0.87%	34
2019 Q2	$1.12M	Buy	27,437 +1,486	+6%	+$59K	1.19%	20
2019 Q1	$1.05M	Sell	25,951 -7,927	-23%	-$317K	1.36%	20
2018 Q4	$1.4M	Buy	+33,878	New	+$1.41M	0.72%	38

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hayden Royal's PFE Position: Q4 2021 in Review

Hayden Royal opened a new position in Pfizer (PFE) in Q4 2021: 3,281 shares worth $194K. The stake represents 0.45% of the portfolio and ranks #79 among its holdings. This is a return to the name: Hayden Royal previously reported a position in PFE as recently as Q2 2021.

Hayden Royal first reported a position in PFE in Q4 2018 and has held it in 11 quarters since. The position peaked at $4.01M in Q4 2019. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Hayden Royal held 3,281 shares of Pfizer worth $194K as of Q4 2021.
Pfizer was a new Hayden Royal position in Q4 2021.
Pfizer made up 0.45% of Hayden Royal's portfolio in Q4 2021, its #79 holding.
Hayden Royal first reported a position in Pfizer in Q4 2018 and has held it in 11 quarters since.
Hayden Royal's Pfizer position peaked at $4.01M in Q4 2019.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Hayden Royal's 13F filing for Q4 2021, filed 7 Feb 2022.